282
Feasibility of tertiary and quaternary cytoreduction in recurrent epithelial ovarian cancer
Feasibility of tertiary and quaternary cytoreduction in recurrent epithelial ovarian cancer
Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)